RA Capital Management, L.P. 13D and 13G filings for DICE Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-09 5:00 pm Sale |
2023-08-09 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 0 0.000% |
-7,877,862 (Position Closed) |
Filing |
| 2023-06-21 5:00 pm Purchase |
2023-06-18 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 7,877,862 16.500% |
217,247 (+2.84%) |
Filing |
| 2023-03-29 5:14 pm Purchase |
2023-03-27 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 7,660,615 16.100% |
811,704 (+11.85%) |
Filing |
| 2022-10-19 4:37 pm Purchase |
2022-10-17 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 6,848,911 14.400% |
1,640,000 (+31.48%) |
Filing |
| 2021-09-27 4:32 pm Purchase |
2021-09-17 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 5,208,911 14.300% |
5,208,911 (New Position) |
Filing |